Phase I study with the HER1 / VSSP therapeutic vaccine in patients with hormone-castration-resistant prostate cancer, advanced squamous cell carcinoma of the head and neck and colon cancer
Latest Information Update: 14 Oct 2020
At a glance
- Drugs HER-1 vaccine Center of Molecular Immunology (Primary)
- Indications Colon cancer; Head and neck cancer; Prostate cancer; Squamous cell cancer
- Focus Adverse reactions
- 29 Dec 2017 New trial record